Introduction – Addressing Core Blood Specimen Integrity, Additive Compatibility, and Preanalytical Error Reduction Needs
For phlebotomists, clinical laboratory scientists, and hospital laboratory managers, collecting, storing, and transporting blood samples for medical or laboratory analysis requires specialized containers that maintain specimen integrity (prevent hemolysis, preserve analytes) and ensure accurate test results (clinical chemistry, hematology, coagulation, immunoassay, microbiology). Improper tube selection (wrong additive, wrong order of draw) or tube defects can lead to preanalytical errors (misdiagnosis, delayed treatment, repeat phlebotomy). Blood sample collection tubes – specialized containers (glass or plastic, sterile) that may contain additives (e.g., anticoagulants (EDTA, heparin, citrate, fluoride), clotting agents (silica, thrombin), or preservatives) depending on the type of test to be performed – directly address these specimen integrity, additive compatibility, and preanalytical variability challenges. These tubes are often vacuum-sealed to draw a precise volume of blood when used with a needle (vacutainer system), ensuring consistent blood-to-additive ratio. Key tube types include: whole blood sampling tubes (EDTA for hematology (CBC), blood banking; heparin for chemistry; sodium citrate for coagulation studies), serum sampling tubes (clot activator (silica) for serum chemistry, immunology), plasma sampling tubes (lithium heparin for plasma chemistry, STAT tests, heparin or EDTA for plasma separation). As the global volume of diagnostic lab tests increases (over 5 billion blood draws annually), hospitals and clinics adopt safety-engineered blood collection devices (needlestick prevention), and new test methods require specialized tubes (cell-free DNA (cfDNA) BCT tubes for liquid biopsy, RNA stabilizing tubes), the market for vacuum blood collection tubes across hospitals, scientific research institutions, and other settings is steadily growing. This deep-dive analysis integrates QYResearch’s latest forecasts (2026–2032), sample type segmentation, and clinical laboratory insights.
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Blood Sample Collection Tube – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Blood Sample Collection Tube market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Blood Sample Collection Tube was estimated to be worth US7330millionin2025andisprojectedtoreachUS7330millionin2025andisprojectedtoreachUS 11180 million, growing at a CAGR of 6.3% from 2026 to 2032. A Blood Sample Collection Tube is a specialized container used to collect, store, and transport blood samples for medical or laboratory analysis. These tubes are typically made of glass or plastic, are sterile, and may contain additives (e.g., anticoagulants, clotting agents, or preservatives) depending on the type of test to be performed. They are often vacuum-sealed to draw a precise volume of blood when used with a needle.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6092253/blood-sample-collection-tube
Core Keywords (Embedded Throughout)
- Blood sample collection tube
- Vacuum blood collection tube
- Whole blood tube
- Serum separation tube
- Plasma preparation tube
Market Segmentation by Sample Type and End-Use Sector
The blood sample collection tube market is segmented below by both intended specimen (type) and user facility (application). Understanding this matrix is essential for tube manufacturers targeting specific laboratory test menus (hematology, chemistry, coagulation, blood bank, immunology) and additive requirements.
By Type (Additive / Specimen Type):
- Whole Blood Sampling Tube (EDTA (lavender top) for hematology (complete blood count, CBC), blood bank (blood typing, DAT), HbA1c (glycated hemoglobin), HIV viral load. Sodium citrate (light blue top) for coagulation testing (PT, APTT, fibrinogen). Sodium fluoride (gray top) for glucose, lactate)
- Serum Sampling Tube (clot activator (silica) (red top, gold top (SST – serum separator tube) for serum chemistry (electrolytes, renal function, liver enzymes), immunology (antibody detection), endocrinology (hormones), therapeutic drug monitoring (TDM))
- Plasma Sampling Tube (lithium heparin (green top) for plasma chemistry (STAT tests), drug levels. Sodium heparin for heparinized whole blood. EDTA for plasma separation)
- Other (cell-free DNA (cfDNA) BCT (streck) for liquid biopsy (prenatal testing, cancer). RNA stabilizing tubes (PAXgene) for gene expression)
By Application:
- Hospital (clinical laboratories (central lab, STAT lab), emergency department (ED), inpatient phlebotomy, outpatient clinics, blood bank)
- Scientific research institutions (research labs, biobanking, clinical research organizations (CROs), academic medical centers)
- Others (diagnostic reference labs, blood donation centers)
Industry Stratification: Vacuum Blood Collection Tube – Additives and Clinical Use
Order of draw (to avoid additive cross-contamination):
- Blood culture bottles (sterile).
- Sodium citrate (light blue) – coagulation.
- Serum tube (red, gold) – chemistry / immunology.
- Heparin (green) – plasma chemistry.
- EDTA (lavender) – hematology.
- Sodium fluoride (gray) – glucose.
Safety consideration: plastic tubes (no breakage risk) vs glass (may break).
Recent 6-Month Industry Data (September 2025 – February 2026)
- Blood Collection Tube Market: 7.33Bin2025,projected7.33Bin2025,projected11.18B by 2032, 6.3% CAGR.
- BD (Becton Dickinson) (November 2025): No withdrawal of blood collection tubes (2023 shortage).
- Liquid Biopsy (December 2025): cfDNA BCT tubes (Streck) for non-invasive prenatal testing (NIPT), cancer monitoring.
- Innovation data (Q4 2025): BD “Vacutainer Plus Plastic Serum Tube” – silicone-coated interior (prevents hemolysis), clot activator, stable up to 8 days (refrigerated). Target: clinical chemistry.
Typical User Case – Hospital Clinical Chemistry (Serum Tube)
A patient presents for annual physical. Phlebotomist collects blood into gold top serum separator tube (SST).
Processing: centrifuge (10 min), serum separated (gel barrier).
Analytes: electrolytes (Na,K,Cl), BUN, creatinine, glucose, liver enzymes (ALT, AST), cholesterol panel.
Result: reported to EHR.
Technical Difficulties and Current Solutions
Despite maturity, blood sample collection tubes face four persistent technical hurdles:
- Hemolysis (RBC rupture during collection or transport). Smooth tube interior (silicone coating), avoid vigorous mixing, strict phlebotomy technique.
- Clot formation in EDTA tube (rare, pseudothrombocytopenia). Mix tube immediately (8-10 inversions).
- Inadequate fill volume (affects blood-to-additive ratio). Vacuum sealed to draw precise volume (2 mL, 4 mL, 6 mL, 10 mL).
- Clotting in serum tube (incomplete clot, fibrin strands). Wait 30 minutes before centrifugation, use clot activator.
Exclusive Industry Observation – The Blood Collection Tube Market by Sample Type and Setting
Based on QYResearch’s interviews with 75 laboratory directors (October 2025 – January 2026), serum tubes (chemistry) and EDTA tubes (hematology) highest volume; plasma tubes for STAT labs.
Serum – 40% of tubes (chemistry, immunology).
EDTA – 30% (CBC, HbA1c).
Citrate – 10% (coagulation).
Other – 20%.
For suppliers, key strategy: offer serum separator tubes (SST) for clinical chemistry; EDTA tubes for hematology; cfDNA BCT for liquid biopsy; focus on plastic, safety-engineered designs.
Complete Market Segmentation (as per original data)
The Blood Sample Collection Tube market is segmented as below:
Major Players:
ELITech Group, Radiometer Medical, F.L. Medical, Sarstedt, Improve Medical, BD, ALIFAX, Nuova Aptaca, PLASTI LAB, Oü InterVacTechnology, Biosigma, Vital Diagnostics, ENVASES FARMACEUTICOS, Tenko International Group, BPC BioSed, Beijing Hanbaihan Medical
Segment by Type:
Whole Blood Sampling Tube, Serum Sampling Tube, Plasma Sampling Tube, Other
Segment by Application:
Hospital, Scientific research institutions, Others
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
